Analysts Set Hinge Health Inc. (NYSE:HNGE) Target Price at $46.00

Hinge Health Inc. (NYSE:HNGE - Get Free Report) has been assigned an average rating of "Buy" from the thirteen brokerages that are covering the stock, Marketbeat reports. Thirteen analysts have rated the stock with a buy rating. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $46.00.

Several brokerages have recently weighed in on HNGE. Truist Financial began coverage on Hinge Health in a report on Monday. They issued a "buy" rating and a $48.00 price target on the stock. Bank of America began coverage on Hinge Health in a report on Monday. They issued a "buy" rating and a $42.00 price target on the stock. Stifel Nicolaus assumed coverage on Hinge Health in a report on Monday. They issued a "buy" rating and a $48.00 price target on the stock. Morgan Stanley assumed coverage on Hinge Health in a report on Monday. They set an "overweight" rating and a $46.00 price objective on the stock. Finally, Canaccord Genuity Group initiated coverage on Hinge Health in a report on Monday. They set a "buy" rating and a $52.00 price objective on the stock.

Hinge Health Trading Up 4.7%

Shares of NYSE HNGE traded up $1.79 during midday trading on Monday, hitting $39.79. The company's stock had a trading volume of 771,425 shares, compared to its average volume of 1,215,089. Hinge Health has a 12-month low of $33.42 and a 12-month high of $43.80.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.